Macclesfield, United Kingdom

James Kirkham

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Infex Therapeutics Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Kirkham. Retrieved from https://idiyas.com/inventor/james-kirkham-3dynpofv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James Kirkham: Innovator in Antibacterial Compounds

Introduction

James Kirkham is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating bacterial infections. His innovative work focuses on enhancing the efficacy of antibacterial agents.

Latest Patents

James Kirkham holds a patent for the "Synthesis of pyrrole acid derivatives." This invention pertains to the synthesis of compounds that can be utilized in conjunction with other antibacterial agents, specifically a class known as carbapenems. The compounds produced through his novel methods serve as enzyme inhibitors, particularly targeting metallo-β-lactamase enzymes.

Career Highlights

Kirkham is associated with Infex Therapeutics Limited, where he applies his expertise in developing new antibacterial therapies. His work is crucial in the ongoing battle against antibiotic resistance, a growing concern in modern medicine.

Collaborations

James collaborates with esteemed colleagues, including Andrew Wilkinson and Ian Cooper. Their combined efforts contribute to advancing research in antibacterial treatments.

Conclusion

James Kirkham's innovative work in synthesizing antibacterial compounds positions him as a key figure in the fight against bacterial infections. His contributions are vital for the development of effective treatments in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…